Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7302)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abuodeh Y, Naghavi AO, Ahmed KA, Venkat PS, Kim Y, Kis B, Choi J, Biebel B, Sweeney J, Anaya DA, Kim R, Malafa M, Frakes JM, Hoffe SE, El-Haddad G. Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization. World J Gastroenterol 2016; 22(47): 10406-10414 [PMID: 28058021 DOI: 10.3748/wjg.v22.i47.10406] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i47/10406.htm |
| Number | Citing Articles |
| 1 |
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
|
| 2 |
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman F. Montasser, Hany Said. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma. European Radiology 2018; 28(12): 5356 doi: 10.1007/s00330-018-5425-z
|
| 3 |
Remco Bastiaannet, Martin A. Lodge, Hugo W.A.M. de Jong, Marnix G.E.H. Lam. The Unique Role of Fluorodeoxyglucose-PET in Radioembolization. PET Clinics 2019; 14(4): 447 doi: 10.1016/j.cpet.2019.06.002
|
| 4 |
Alice Boilève, Marc Hilmi, Matthieu Delaye, Annemilaï Tijeras-Raballand, Cindy Neuzillet. Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?. Cancers 2021; 13(11): 2708 doi: 10.3390/cancers13112708
|
| 5 |
Sang Hyun Hwang, Hye-Suk Hong, Dongwoo Kim, Gyoung Min Kim, Hye Won Lee, Misu Lee, Do Young Kim, Mi-Ae Park, Mijin Yun. Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization. Clinical Nuclear Medicine 2022; 47(6): e437 doi: 10.1097/RLU.0000000000004128
|
| 6 |
Paul Blanc-Durand, Axel Van Der Gucht, Mario Jreige, Marie Nicod-Lalonde, Marina Silva-Monteiro, John O. Prior, Alban Denys, Adrien Depeursinge, Niklaus Schaefer. Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma. Oncotarget 2018; 9(4): 4549 doi: 10.18632/oncotarget.23423
|
| 7 |
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utility. Clinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y
|
| 8 |
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
|
| 9 |
K. V. Lyadov, A. D. Kaprin, A. G. Rerberg, I. A. Kozyrin, V. K. Lyadov, K. V. Maiorov, D. A. Kaprin, O. V. Moroz, D. V. Cherednichenko, I. Yu. Dobreva, V. G. Polushkin, A. A. Khodovsky. Therapy for inoperable hepatocellular carcinoma with selective transarterial radioembolization with yttrium-90 microspheres. Onkologiya. Zhurnal imeni P.A.Gertsena 2018; 7(3): 55 doi: 10.17116/onkolog20187355
|
| 10 |
Vincent Vinh-Hung, Hendrik Everaert, Karim Farid, Navid Djassemi, Jacqueline Baudin-Veronique, Stefanos Bougas, Yuriy Michailovich, Clarisse Joachim-Contaret, Elsa Cécilia-Joseph, Claire Verschraegen, Nam P Nguyen. Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastases. World Journal of Radiology 2017; 9(7): 312-320 doi: 10.4329/wjr.v9.i7.312
|
| 11 |
Kyung Jin Cho, Nam Kyu Choi, Min Ho Shin, A Ri Chong. Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection. Annals of Hepato-Biliary-Pancreatic Surgery 2017; 21(4): 194 doi: 10.14701/ahbps.2017.21.4.194
|
| 12 |
Philippe d’Abadie, Stephan Walrand, Renaud Lhommel, Michel Hesse, Ivan Borbath, François Jamar. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology 2022; 29(4): 2422 doi: 10.3390/curroncol29040196
|
| 13 |
Samar Ramzy Ragheb, Amr Mahmoud Ahmed Abelsamad, Moustafa Mahmoud Abelkawy, Osama Abu Elnaga Khalaf Nasr. Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional management. Egyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-020-00158-6
|
| 14 |
Justine Perrin, Karim Farid, Hilde Van Parijs, Olena Gorobets, Vincent Vinh-Hung, Nam P Nguyen, Navid Djassemi, Mark De Ridder, Hendrik Everaert. Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis. World Journal of Clinical Oncology 2022; 13(4): 287-302 doi: 10.5306/wjco.v13.i4.287
Abstract(388) |
Core Tip(319) |
Full Article(HTML)(1201)
|
Full Article (PDF)-1787K(165)
|
Full Article (Word)-1218K(94)
|
Audio-248K(0)
|
Peer-Review Report-281K(59)
|
Answering Reviewers-295K(70)
|
Times Cited (0)
|
Total Visits (5141)
|
Open
|